Ensure your mastery of need-to-know Canadian pharmacology nursing principles with the Study Guide for Lilley’s Pharmacology for Canadian Health Care Practice, 5th Edition. Designed to accompany the Lilley’s textbook, this dynamic study guide helps you better understand, retain, and apply the information and concepts from each chapter of the text. Worksheets for each chapter include multiple-choice review questions, critical thinking and application questions, case studies, and a wealth of other learning activities to help you fully prepare for credentialling exams.
1. Cover image - p. i 2. Title page - p. ii 3. Table of Contents - p. iii 4. Pharmaceutical Abbreviations - p. iii 5. Copyright - p. iv 6. Student study tips - p. vii 7. Part 1. Pharmacology Basics - p. xxvi 8. 1. Nursing practice in Canada and drug therapy - p. 1 9. 2. Pharmacological principles - p. 4 10. 3. Legal and ethical considerations - p. 7 11. 4. Patient-focused considerations - p. 9 12. 5. Gene therapy and pharmacogenomics - p. 11 13. 6. Medication errors: Preventing and responding - p. 12 14. 7. Patient education and drug therapy - p. 14 15. 8. Over-the-counter drugs and natural health products - p. 16 16. 9. Vitamins and minerals - p. 19 17. 10. Principles of drug administration - p. 21 18. Part 2. Drugs Affecting the Central Nervous System - p. 23 19. 11. Analgesic drugs - p. 24 20. 12. General and local anaesthetics - p. 27 21. 13. Central nervous system depressants and muscle relaxants - p. 30 22. 14. Central nervous system stimulants and related drugs - p. 32 23. 15. Antiepileptic drugs - p. 34 24. 16. Antiparkinsonian drugs - p. 37 25. 17. Psychotherapeutic drugs - p. 39 26. 18. Substance use disorder - p. 42 27. Part 3. Drugs Affecting the Autonomic Nervous System - p. 43 28. 19. Adrenergic drugs - p. 44 29. 20. Adrenergic-blocking drugs - p. 47 30. 21. Cholinergic drugs - p. 49 31. 22. Cholinergic-blocking drugs - p. 51 32. Part 4. Drugs Affecting the Cardiovascular and Renal Systems - p. 52 33. 23. Antihypertensive drugs - p. 53 34. 24. Antianginal drugs - p. 56 35. 25. Heart failure drugs - p. 58 36. 26. Diuretic drugs - p. 61 37. 27. Antidysrhythmic drugs - p. 64 38. 28. Coagulation modifier drugs - p. 66 39. 29. Antilipemic drugs - p. 69 40. 30. Fluids and electrolytes - p. 71 41. Part 5. Drugs Affecting the Endocrine System - p. 72 42. 31. Pituitary drugs - p. 73 43. 32. Thyroid and antithyroid drugs - p. 75 44. 33. Antidiabetic drugs - p. 78 45. 34. Adrenal drugs - p. 80 46. 35. Women’s health drugs - p. 82 47. 36. Men’s health drugs - p. 84 48. Part 6. Drugs Affecting the Respiratory System - p. 85 49. 37. Antihistamines, decongestants, antitussives, and expectorants - p. 86 50. 38. Respiratory drugs - p. 88 51. Part 7. Drugs Affecting the Gastrointestinal System and Nutrition - p. 89 52. 39. Acid-controlling drugs - p. 90 53. 40. Antidiarrheal drugs and laxatives - p. 92 54. 41. Antiemetic and antinausea drugs - p. 95 55. 42. Nutritional supplements - p. 97 56. Part 8. Anti-infective and Anti-inflammatory Drugs - p. 99 57. 43. Antibiotics part 1: Sulfonamides, penicillins, cephalosporins, macrolides, and tetracyclines - p. 100 58. 44. Antibiotics part 2: Aminoglycosides, fluoroquinolones, and other drugs - p. 102 59. 45. Antiviral drugs - p. 104 60. 46. Antitubercular drugs - p. 106 61. 47. Antifungal drugs - p. 108 62. 48. Antimalarial, antiprotozoal, and anthelmintic drugs - p. 110 63. 49. Anti-inflammatory and antigout drugs - p. 112 64. Part 9. Immune and Biological Modifiers and Chemotherapeutic Drugs - p. 113 65. 50. Immunosuppressant drugs - p. 114 66. 51. Immunizing drugs and pandemic preparedness - p. 116 67. 52. Antineoplastic drugs part 1: Cancer overview and cell cycle–specific drugs - p. 118 68. 53. Antineoplastic drugs part 2: Cell cycle–nonspecific and miscellaneous drugs - p. 121 69. 54. Biological response–modifying drugs and antirheumatic drugs - p. 123 70. Part 10. Miscellaneous Therapeutics: Hematological, Dermatological, Ophthalmic, and Otic Drugs - p. 124 71. 55. Anemia drugs - p. 125 72. 56. Dermatological drugs - p. 127 73. 57. Ophthalmic drugs - p. 129 74. 58. Otic drugs - p. 132 75. Overview of dosage calculations - p. 134 76. Answer sheet - p. 156
Ensure your mastery of need-to-know Canadian pharmacology nursing principles with the Study Guide for Lilley’s Pharmacology for Canadian Health Care Practice, 5th Edition. Designed to accompany the Lilley’s textbook, this dynamic study guide helps you better understand, retain, and apply the information and concepts from each chapter of the text. Worksheets for each chapter include multiple-choice review questions, critical thinking and application questions, case studies, and a wealth of other learning activities to help you fully prepare for credentialling exams.
1. Cover image - p. i 2. Title page - p. ii 3. Table of Contents - p. iii 4. Pharmaceutical Abbreviations - p. iii 5. Copyright - p. iv 6. Student study tips - p. vii 7. Part 1. Pharmacology Basics - p. xxvi 8. 1. Nursing practice in Canada and drug therapy - p. 1 9. 2. Pharmacological principles - p. 4 10. 3. Legal and ethical considerations - p. 7 11. 4. Patient-focused considerations - p. 9 12. 5. Gene therapy and pharmacogenomics - p. 11 13. 6. Medication errors: Preventing and responding - p. 12 14. 7. Patient education and drug therapy - p. 14 15. 8. Over-the-counter drugs and natural health products - p. 16 16. 9. Vitamins and minerals - p. 19 17. 10. Principles of drug administration - p. 21 18. Part 2. Drugs Affecting the Central Nervous System - p. 23 19. 11. Analgesic drugs - p. 24 20. 12. General and local anaesthetics - p. 27 21. 13. Central nervous system depressants and muscle relaxants - p. 30 22. 14. Central nervous system stimulants and related drugs - p. 32 23. 15. Antiepileptic drugs - p. 34 24. 16. Antiparkinsonian drugs - p. 37 25. 17. Psychotherapeutic drugs - p. 39 26. 18. Substance use disorder - p. 42 27. Part 3. Drugs Affecting the Autonomic Nervous System - p. 43 28. 19. Adrenergic drugs - p. 44 29. 20. Adrenergic-blocking drugs - p. 47 30. 21. Cholinergic drugs - p. 49 31. 22. Cholinergic-blocking drugs - p. 51 32. Part 4. Drugs Affecting the Cardiovascular and Renal Systems - p. 52 33. 23. Antihypertensive drugs - p. 53 34. 24. Antianginal drugs - p. 56 35. 25. Heart failure drugs - p. 58 36. 26. Diuretic drugs - p. 61 37. 27. Antidysrhythmic drugs - p. 64 38. 28. Coagulation modifier drugs - p. 66 39. 29. Antilipemic drugs - p. 69 40. 30. Fluids and electrolytes - p. 71 41. Part 5. Drugs Affecting the Endocrine System - p. 72 42. 31. Pituitary drugs - p. 73 43. 32. Thyroid and antithyroid drugs - p. 75 44. 33. Antidiabetic drugs - p. 78 45. 34. Adrenal drugs - p. 80 46. 35. Women’s health drugs - p. 82 47. 36. Men’s health drugs - p. 84 48. Part 6. Drugs Affecting the Respiratory System - p. 85 49. 37. Antihistamines, decongestants, antitussives, and expectorants - p. 86 50. 38. Respiratory drugs - p. 88 51. Part 7. Drugs Affecting the Gastrointestinal System and Nutrition - p. 89 52. 39. Acid-controlling drugs - p. 90 53. 40. Antidiarrheal drugs and laxatives - p. 92 54. 41. Antiemetic and antinausea drugs - p. 95 55. 42. Nutritional supplements - p. 97 56. Part 8. Anti-infective and Anti-inflammatory Drugs - p. 99 57. 43. Antibiotics part 1: Sulfonamides, penicillins, cephalosporins, macrolides, and tetracyclines - p. 100 58. 44. Antibiotics part 2: Aminoglycosides, fluoroquinolones, and other drugs - p. 102 59. 45. Antiviral drugs - p. 104 60. 46. Antitubercular drugs - p. 106 61. 47. Antifungal drugs - p. 108 62. 48. Antimalarial, antiprotozoal, and anthelmintic drugs - p. 110 63. 49. Anti-inflammatory and antigout drugs - p. 112 64. Part 9. Immune and Biological Modifiers and Chemotherapeutic Drugs - p. 113 65. 50. Immunosuppressant drugs - p. 114 66. 51. Immunizing drugs and pandemic preparedness - p. 116 67. 52. Antineoplastic drugs part 1: Cancer overview and cell cycle–specific drugs - p. 118 68. 53. Antineoplastic drugs part 2: Cell cycle–nonspecific and miscellaneous drugs - p. 121 69. 54. Biological response–modifying drugs and antirheumatic drugs - p. 123 70. Part 10. Miscellaneous Therapeutics: Hematological, Dermatological, Ophthalmic, and Otic Drugs - p. 124 71. 55. Anemia drugs - p. 125 72. 56. Dermatological drugs - p. 127 73. 57. Ophthalmic drugs - p. 129 74. 58. Otic drugs - p. 132 75. Overview of dosage calculations - p. 134 76. Answer sheet - p. 156